<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:42:28Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3224827" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3224827</identifier><datestamp>2011-11-29</datestamp><setSpec>molvis</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mol Vis</journal-id>
      <journal-id journal-id-type="publisher-id">MV</journal-id>
      <journal-title-group>
        <journal-title>Molecular Vision</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1090-0535</issn>
      <publisher>
        <publisher-name>Molecular Vision</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3224827</article-id>
      <article-id pub-id-type="pmcid">PMC3224827</article-id>
      <article-id pub-id-type="pmc-uid">3224827</article-id>
      <article-id pub-id-type="pmid">22128244</article-id>
      <article-id pub-id-type="publisher-id">322</article-id>
      <article-id pub-id-type="publisher-id">2011MOLVIS0153</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Identification of a novel <italic>FRMD7</italic> splice variant and functional analysis of two <italic>FRMD7</italic> transcripts during human NT2 cell differentiation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Yingzhi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pu</surname>
            <given-names>Jiali</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Zhirong</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>Shanhu</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>FanYing</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zhu</surname>
            <given-names>Lijun</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tian</surname>
            <given-names>Jun</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Luo</surname>
            <given-names>Jianhong</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Zhang</surname>
            <given-names>Baorong</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <aff id="aff1"><label>1</label>Department of Neurology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China</aff>
        <aff id="aff2"><label>2</label>Department of Neurology, Zhejiang Hospital, Hangzhou, China</aff>
        <aff id="aff3"><label>3</label>Department of Neurobiology, Institute of Neuroscience, Zhejiang University School of Medicine, Hangzhou, China</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Correspondence to: Baorong Zhang, M.D., Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310009, Peopleâs Republic of China; Phone: +86-571-87784752; FAX: +86-571-87784750; email: <email xlink:href="brzhang@zju.edu.cn">brzhang@zju.edu.cn</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>11</month>
        <year>2011</year>
      </pub-date>
      <volume>17</volume>
      <fpage>2986</fpage>
      <lpage>2996</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>4</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>08</day>
          <month>11</month>
          <year>2011</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2011 Molecular Vision.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <license-p>This is an open-access article distributed under the terms of the
        Creative Commons Attribution License, which permits unrestricted use,
        distribution, and reproduction in any medium, provided the original
        work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p>FERM domain containing protein 7 (<italic>FRMD7</italic>) mutations are associated with X-linked idiopathic congenital nystagmus (ICN). The purpose of this study is to identify a novel splice variant of <italic>FRMD7</italic> (<italic>FRMD7-S</italic>) in both humans and mice with a shortened exon 4 relative to the original form of <italic>FRMD7</italic> (<italic>FRMD7-FL</italic>),and to detect the role of <italic>FRMD7-FL</italic> and <italic>FRMD7-S</italic> in the process of neuronal development.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>The splice variant of <italic>FRMD7</italic> was identified by PCR. Expression levels of h<italic>FRMD7-FL</italic> and h<italic>FRMD7-S</italic> transcripts in developing human fetal brain were tested by RTâPCR, and expression levels in the human pluripotent embryonic carcinoma NTera 2/cl.D1 (NTERA-2; NT2) cell line with all-trans retinoic acid (ATRA) or bone morphogenetic protein-2 (BMP-2) treatment were tested by real-time qPCR. hemaglutinin (HA)-tagged recombinant plasmids DNA encoding h<italic>FRMD7-FL</italic> and Myc-tagged recombinant plasmids DNA encoding h<italic>FRMD7-S</italic> were used to transiently transfect the human NT2 cells. Further, immunofluorescence experiments were performed to determine the co-localization of the two fusion proteins. Finally, using co-immunoprecipitation analyses, we demonstrated that FRMD7-FL and FRMD7-S interacted with each other.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>A novel splice variant of <italic>FRMD7</italic> (<italic>FRMD7-S</italic>) with a shortened exon 4 relative to the original form of <italic>FRMD7</italic> (<italic>FRMD7-FL</italic>) was identified from the cDNA of the human NT2 cell line and mouse fetal brain. The <italic>FRMD7</italic> transcripts showed similar tissue distributions and were upregulated following all trans retinoic acid (ATRA)-induced differentiation of NT2 cells. FRMD7-FL and FRMD7-S co-localized and co-immunoprecipitated with each other. Further, overexpression of <italic>FRMD7-FL</italic> in NT2 cells resulted in altered neurite development and upregulation of <italic>FRMD7-S</italic>.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Although the significance of the 45 bp deletion remains unknown, our observations suggest that the <italic>FRMD7</italic> isoforms may play a significant role during neuronal differentiation and development.</p>
        </sec>
      </abstract>
      <custom-meta-group>
        <custom-meta>
          <meta-name>GalleyStatus</meta-name>
          <meta-value>Export to XML</meta-value>
        </custom-meta>
        <custom-meta>
          <meta-name>corr-author</meta-name>
          <meta-value>Zhang</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Idiopathic congenital nystagmus (ICN) is an oculomotor disorder characterized by involuntary horizontal oscillations of the eyes that presents at birth or appears in the first months of life, but does not usually worsen over time. ICN is distinct from other ocular disorders in which nystagmus is acquired later in life (e.g., cataracts, glaucoma, albinism) or is accompanied by eye, brain, or other health abnormalities [<xref ref-type="bibr" rid="r1">1</xref>]. The prevalence of ICN is estimated to be 24 per 10,000 [<xref ref-type="bibr" rid="r2">2</xref>], and although some techniques can improve vision (e.g., glasses, contact lenses, eye muscle surgery), nystagmus is usually permanent and cannot be corrected or cured [<xref ref-type="bibr" rid="r3">3</xref>].</p>
      <p>Previous studies have speculated that ICN represents a primary defect in the brain regions involved in ocular motor control [<xref ref-type="bibr" rid="r4">4</xref>], although the precise pathogenic mechanisms underlying ICN are currently unknown. Mutations in the human FERM domain containing protein 7 (<italic>FRMD7</italic>) gene (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_194277">NM_194277</ext-link>), which encodes the FERM domain containing protein 7 that is a member of the FERM family, are associated with X-linked ICN [<xref ref-type="bibr" rid="r5">5</xref>]. Approximately 50% of X-linked pedigrees and 5% of sporadic ICN cases have been linked to <italic>FRMD7</italic> mutations, and more than 35 <italic>FRMD7</italic> mutations have been reported worldwide in families with X-linked ICN from various ethnic backgrounds [<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r7">7</xref>].</p>
      <p>The 298 amino acid FERM domain was originally identified in protein 4.1 [<xref ref-type="bibr" rid="r8">8</xref>], and subsequent studies reported the structural, transport, and membrane-localizing functions of this domain [<xref ref-type="bibr" rid="r9">9</xref>-<xref ref-type="bibr" rid="r11">11</xref>]. Notably, the hFRMD7-FL protein is highly homologous to FARP1 (FERM, RhoGEF, and pleckstrin domain protein 1) and FARP2 proteins, which are known to play significant roles in neuronal development. FARP1 is necessary and sufficient for promoting lateral motor column dendritic growth, and FARP2 is a key molecule involved in the response of neuronal growth cones to class-3 semaphorins [<xref ref-type="bibr" rid="r12">12</xref>,<xref ref-type="bibr" rid="r13">13</xref>]. Moreover, recent studies have demonstrated that inhibition of <italic>FRMD7</italic> expression in mouse neuroblastoma cell line (NEURO2A) during neuronal differentiation is associated with significant delays in neurite growth and disrupted F-actin/G-actin dynamics [<xref ref-type="bibr" rid="r14">14</xref>]. In a mouse model, <italic>FRMD7</italic> expression levels were low in all adult tissue samples, whereas <italic>FRMD7</italic> expression levels were higher in embryos and underwent a sharp increase at embryonic day 18 in brain tissue [<xref ref-type="bibr" rid="r15">15</xref>]. These findings provide evidence that <italic>FRMD7</italic> plays a critical role during neuronal morphogenesis, in synapse function, and in neurite growth, but further studies will be required to uncover the precise mechanisms associated with <italic>FRMD7</italic> function.</p>
      <p>The NT2 cell line, which is a human embryonic carcinoma cell line, differentiates into post-mitotic neuron-like cells following treatment with all trans retinoic acid (ATRA) [<xref ref-type="bibr" rid="r16">16</xref>,<xref ref-type="bibr" rid="r17">17</xref>] and into non-neural epithelial cell lineages following exposure to bone morphogenetic protein 2 (BMP-2) [<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r19">19</xref>]. Therefore, NT2 cells provide an ideal model system that mimics normal neuronal differentiation in the brain according to many established criteria.</p>
      <p>Previous studies have revealed that alternative splicing occurs much more frequently in the brain relative to other tissues [<xref ref-type="bibr" rid="r20">20</xref>,<xref ref-type="bibr" rid="r21">21</xref>], and alternative splicing is increasingly recognized for its role in neurologic disease [<xref ref-type="bibr" rid="r22">22</xref>,<xref ref-type="bibr" rid="r23">23</xref>]. In the current study, we have identified and characterized a novel <italic>FRMD7</italic> splice variant in humans and mice, h<italic>FRMD7-S</italic> (GenBank <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/FJ717411">FJ717411</ext-link>) and m<italic>FRMD7-S</italic>, respectively; the splice variant contains a 45 bp truncation in the fourth exon and produces an altered form of the FERM domain. Herein, we investigate the expression patterns, role in neurite development, subcellular localization, and interactions associated with the <italic>FRMD7-S</italic> splice variant relative to the original <italic>FRMD7-FL</italic> isoform in NT2 cells.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Cell culture and ATRA/BMP-2-induced differentiation</title>
        <p>Human NT2 cells (Cell Culture Center of Peking Union Medical College, Peking, China) were maintained in DMEM/F12 medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 100Â Î¼g/ml streptomycin. Prior to the induction of differentiation, the NT2 cells were incubated in 25 cm<sup>2</sup> cell culture flasks in 4Â ml of medium in a 37Â Â°C, high humidity, 5% CO<sub>2</sub> incubator. The cells were trypsinized and sub-cultured at a ratio of 1:3 twice weekly. For the time course analyses, the NT2 cells were seeded on a 3.0Ã10<sup>6</sup>/10 cm<sup>2</sup> plate and treated the following day with 10Â Î¼M all-trans retinoic acid (ATRA) dissolved in DMSO [<xref ref-type="bibr" rid="r16">16</xref>,<xref ref-type="bibr" rid="r17">17</xref>] or with 50 ng/ml bone morphogenetic protein-2 (BMP-2) dissolved in normal saline [<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r19">19</xref>]. The cells were collected at 12, 24, 36, 48, and 72 h after treatment for the early time points. For the later time points (5, 8, and 12 days), the cells were reseeded every three days in the continued presence of ATRA or BMP-2 and collected on the corresponding days.</p>
      </sec>
      <sec>
        <title>Collection of human and mouse fetal tissue</title>
        <p>Freshly isolated 16-week post-conception (wpc) aborted human fetal tissues were collected from the Women's Hospital School Of Medicine Zhejiang University. The experimental procedures were approved by the Human Ethical Committee of the Zhejiang University. Mouse fetal brain tissue was isolated from 18-day mouse fetuses. A scissors was used to produce 1â3Â mm<sup>3</sup> pieces of tissue, which were snap frozen in cryogenic vials in liquid nitrogen and stored at â80Â Â°C. Total RNA from each sample was prepared for subsequent RTâPCR experiments.</p>
      </sec>
      <sec>
        <title>RNA isolation, reverse transcription PCR, and quantitative real-time PCR analysis</title>
        <p>Total RNA was isolated from human and mouse fetal tissues and NT2 cells using TRIZOL reagent (Invitrogen, San Diego, CA), according to the manufacturerâs instructions. Real-time quantitative PCR (RT-qPCR) assays were performed using a Light Cycler<sup>TM</sup> real-time PCR thermocycler (Roche, Shanghai, China). Briefly, 1.5Â Î¼g of total RNA was reverse transcribed using oligo (dT) 12â18 with M-MLV Reverse Transcriptase (Promega, Madison, WI) according to the manufacturer's instructions. Relative levels of gene expression were analyzed using the SYBR<sup>Â®</sup> Premix Ex Taqâ¢ (TaKaRa, Dalian, China) using the recommended PCR conditions. The sequences of the RT-qPCR primers are shown in <xref ref-type="table" rid="t1">Table 1</xref>. The relative mRNA levels of target genes were calculated relative to glyceraldehyde-3-phosphate dehydrogenase (<italic>GAPDH</italic>) using the (=2<sup>-â³â³C</sup><sub>T</sub>) method [<xref ref-type="bibr" rid="r24">24</xref>].</p>
        <table-wrap id="t1" position="float">
          <label>Table 1</label>
          <caption>
            <title>Primer sequences.</title>
          </caption>
          <table frame="hsides" rules="groups">
            <col width="29" span="1"/>
            <col width="156" span="1"/>
            <col width="528" span="1"/>
            <thead>
              <tr>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>ID</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Name</bold>
                </th>
                <th valign="top" align="left" scope="col" rowspan="1" colspan="1">
                  <bold>Sequence</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td colspan="3" valign="top" align="left" scope="col" rowspan="1">
                  <bold>Primer for RTâPCR/RT-qPCR</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">p1f<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1"><italic>FRMD7-FL</italic>-f<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">5â²-CAAAGCAGGTAAAAAATCCTAAGG-3â²<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">p1r<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1"><italic>FRMD7-FL</italic>-r<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">5â²-ATGTGAGATACCATCAACGCTGT-3â²<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">p2f<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1"><italic>FRMD7-S</italic>-f<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">5â²-TAACAAAGCAGGTAAAAATGGAC-3â²<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">p2r<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1"><italic>FRMD7-S</italic>-r<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">5â²-AAGATGTGAGATACCATCAACG-3â²<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">p3f<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1"><italic>GAPDH</italic>-f<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">5â²- CCCACTCCTCCACCTTTGAC-3â²<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">p3r<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1"><italic>GAPDH</italic>-r<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">5â²- CATACCAGGAAATGAGCTTGACAA-3â²<hr/></td>
              </tr>
              <tr>
                <td colspan="3" valign="top" align="left" scope="col" rowspan="1">
                  <bold>Primer for cloning</bold>
                  <hr/>
                </td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">pAf<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">pcDNA3.1-FRMD7-FL-HA-f<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">5â²-CGCTAGCGCCACCATGCTACATTTAAAAGTGCAGT-3â²<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">pAr<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">pcDNA3.1-FRMD7-FL-HA-r<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">5â²-GCTCGAGTTAAGCGTA<underline>ATCTGGAACATCGTATGGGTA</underline>AGCTAAAAAGTAATTACATG-3â²<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">pBf<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">pcDNA3.1-FRMD7-S-Myc-f<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">5â²-CGCTAGCGCCACCATGCTACATTTAAAAGTGCAGT-3â²<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">pBr<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">pcDNA3.1-FRMD7-S-Myc-r<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">5â²-GCTCGAGTTA<underline>CAGATCCTCTTCAGAGATGAGTTTCTGCTC</underline>AGCTAAAAAGTAATTACATG-3â²<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">pCf<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">pEGFP-FRMD7-FL-f<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">5â²-CGCTAGCATGATTCCCAGAAGAT-3â²<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">pCr<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">pEGFP-FRMD7-FL-r<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">5â²-GCTCGAGAGCTAAAAAGTAATTACA-3â²<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">pDf<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">pDsRed-FRMD7-S-f<hr/></td>
                <td valign="top" align="left" rowspan="1" colspan="1">5â²-CGCTAGCATGATTCCCAGAAGAT-3â²<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="center" scope="row" rowspan="1" colspan="1">pDr</td>
                <td valign="top" align="center" rowspan="1" colspan="1">pDsRed-FRMD7-S-r</td>
                <td valign="top" align="left" rowspan="1" colspan="1">5â²-GCTCGAGAGCTAAAAAGTAATTACA-3â²</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>Underlined nucleotides mark the HA-tag and Myc-tag.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>cDNA clone and plasmid construction</title>
        <p>Human <italic>FRMD7-FL</italic> and <italic>FRMD7-S</italic> genes were isolated from NT2 cell cDNA (synthesized from the total RNA of natural NT2 cells) by PCR amplification using the following primers: 5â²-ATG CTA CAT TTA AAA GTG CAG TTT-3â² and 5â²-TTA AGC TAA AAA GTA ATT ACA TGG T-3â². The mouse <italic>FRMD7-FL</italic> and <italic>FRMD7-S</italic> genes were cloned from 18-day fetal mouse brain cDNA using the following primers: 5â²-GTA TGG ATC CAT GCT CCA TTT AAA AGT G-3â² and 5â²-AGC TAA GAA ATA ATT GCA TGG CTT TAG C-3â². PCR was performed in 25Â Î¼l of a reaction mixture containing DNA polymerase from <italic>Thermococcus kodakaraensis </italic>(KOD) DNA polymerase buffer and 1.25 U KOD DNA polymerase (Toyobo, Osaka, Japan). Subsequent cloning of PCR products into the pEASY-Blunt vector (TransGen Biotech, Beijing, China) was performed using the pEASY-Blunt Cloning Kit for Sequencing (TransGen Biotech). Sequence analyses were performed by the Invitrogen Company (Shanghai, China). To generate eukaryotic expression vectors for h<italic>FRMD7</italic> splice variants, cloned RTâPCR fragments in pEASY-Blunt were used as the template. The hFRMD7-FL cDNA was sub-cloned into pcDNA3.1(+) in frame with an NH<sub>2</sub>-terminal HA tag (hFRMD7-FL-HA) and pEGFP-N1 (pEGFP-hFRMD7-FL) with the pAf/pAr and pCf/pCr primer sets, respectively (<xref ref-type="table" rid="t1">Table 1</xref>). The h<italic>FRMD7-S</italic> gene was subcloned into pcDNA3.1(+) with an NH<sub>2</sub>-terminal Myc tag (hFRMD7-S-Myc) and plasmid pDsRed-N1 (pDsRed-hFRMD7-S) using the pBf/pBr and pDf/pDr primer sets, respectively (<xref ref-type="table" rid="t1">Table 1</xref>). NheI and XhoI were chosen as the cloning sites for all three vectors, and the sequences of all of the expression cassettes were verified.</p>
      </sec>
      <sec>
        <title>Cell transfection and immunofluorescence microscopy</title>
        <p>For transient transfection experiments, the NT2 cells were placed on glass coverslips or cell culture flasks until they reached approximately 60% confluency and were transfected with FuGENE HD transfection reagent (Roche) at a ratio of 1Â Î¼g of DNA to 3Â Î¼l of FuGENE HD per coverslip. The cells were processed for immunofluorescence at 48 h post-transfection. For stable overexpression experiments, G418 (1.2Â Î¼g/ ml medium; Invitrogen) antibiotic selection was performed for 4 weeks. For the immunofluorescence experiments, the induced or transfected NT2 cells were washed with phosphate-buffered saline (PBS) and fixed for 15 min at room temperature in 4% paraformaldehyde (PFA) in PBS. The coverslips were washed twice with ice-cold PBS, and the cells were permeabilized with PBS containing 0.2% Triton X-100 for 10 min at 4Â Â°C. After washing the cells in PBS three times for 5 min (each wash), a blocking solution containing PBS and 10% normal goat serum was applied for 1 h at room temperature. Afterwards, primary antibodies (monoclonal anti-Myc or anti-HA or antibodies; Abmart Inc., Shanghai, China) diluted in a blocking solution were applied overnight at 4Â Â°C or for 1 h at room temperature. In the double-labeling experiments, the cultures were incubated simultaneously with two primary antibodies. After three washes in PBS, the secondary antibodies (Dylight 488, Dylight 594; Jackson ImmunoResearch Laboratories, Inc. West Grove, PA) were diluted 1:250 in a blocking solution and added for 1 h at room temperature in the dark. The secondary antibody solution was decanted and washed three times with PBS for 5 min each in the dark. Finally, the cells were incubated for 5 min with 0.1Â Î¼g/ml DAPI as a nuclear counterstain. After three washes, the coverslips were mounted with a drop of Antifade Mounting Medium (Beyotime Institute of Biotechnology, Suzhou, China) and stored in the dark at â20Â Â°C or 4Â Â°C. The cells were viewed using a Nikon eclipse inverted fluorescence microscope equipped with a Nikon digital camera (Nikon Corporation, Tokyo, Japan). Image overlays and contrast enhancement were performed using Adobe Photoshop CS2 (Adobe Systems Inc. San Jose, CA) software.</p>
      </sec>
      <sec>
        <title>Co-immunoprecipitation and immunoblot analyses</title>
        <p>For co-immunoprecipitation (co-IP) experiments, NT2 cells were transiently co-transfected with 2Â Î¼g of each of the hFRMD7-FL-HA and hFRMD7-S-Myc vectors. At 48 h post-transfection, the total protein been extracted from the cells by using M-PER<sup>Â®</sup> Mammalian Protein Extraction Reagent (Thermo Fisher Scientific Inc., Rockford, IL) following the manufacturer's instructions. Then the ProFoundâ¢ Co-Immunoprecipitation Kit (Thermo Fisher Scientific Inc.) was used for co-IP assays according to the manufacturer's instructions. Control immunoprecipitations were performed in the presence of non-specific immunoglobulins.</p>
      </sec>
      <sec>
        <title>Statistical analyses</title>
        <p>All experiments were done in triplicate, and the data are represented as meanÂ±SEM. Statistical significance between groups was determined using the KolmogorovâSmirnov test and Studentâs <italic>t</italic>-test, as implemented by SPSS13.0 (SPSS Inc., Chicago, IL). Results were considered to be statistically significant when p&lt;0.05.</p>
      </sec>
    </sec>
    <sec>
      <title>Results</title>
      <sec>
        <title>Identification of a novel <italic>FRMD7</italic> splice variant and tissue distribution of two <italic>FRMD7</italic> transcripts</title>
        <p>In RTâPCR experiments to clone the h<italic>FRMD7-FL</italic> gene from NT2 cells, two PCR products were produced. Cloning and sequence analysis of the PCR products indicated that they corresponded to two distinct <italic>FRMD7</italic> mRNAs: the expected original h<italic>FRMD7-FL</italic> mRNA and another unexpected mRNA not described previously, which is referred to herein as h<italic>FRMD7-S</italic>. This novel transcript, which lacks a 45 bp segment in the 5â² region of exon 4, results in the fusion of the 3â² end of exon 3 to the 5â² end of truncated exon 4; therefore, h<italic>FRMD7-S</italic> encodes a putative protein of 699 amino acids (<xref ref-type="fig" rid="f1">Figure 1A,B</xref>). We then performed RTâPCR to confirm the presence of m<italic>FRMD7-S</italic> in 18-day-old fetal mice (<xref ref-type="fig" rid="f1">Figure 1C</xref>). The expression of h<italic>FRMD7-FL</italic> and h<italic>FRMD7-S</italic> transcripts was examined in tissues from 16-wpc human fetal tissue using sequence-specific primers (<xref ref-type="fig" rid="f1">Figure 1D</xref>). We detected high expression of h<italic>FRMD7-FL</italic> in the cerebellum and moderate expression in the cerebral cortex, optic nerve, kidney, testis, and gastric wall. We detected high expression of h<italic>FRMD7-S</italic> in the cerebellum and moderate expression in the kidney, testis, and gastric wall. However, h<italic>FRMD7-S</italic> was not expressed in the optic nerve or cerebral cortex. Neither h<italic>FRMD7-FL</italic> nor h<italic>FRMD7-S</italic> were expressed in the medulla oblongata, pons, or liver. Taken together, these results revealed that h<italic>FRMD7-S</italic> exhibited a similar but limited tissue distribution compared to h<italic>FRMD7-FL</italic> (<xref ref-type="fig" rid="f1">Figure 1E</xref>).</p>
        <fig id="f1" fig-type="figure" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Cloning of a novel <italic>FRMD7</italic> isoform and tissue distribution of the two splice variants. <bold>A</bold>: Components of the FERM domain and gene structure of h<italic>FRMD7-FL</italic>. <bold>B</bold> and <bold>C</bold>: Sequence comparison between h<italic>FRMD7-FL</italic>/m<italic>FRMD7-FL</italic> (<bold>B</bold>) and h<italic>FRMD7-S</italic>/m<italic>FRMD7-S</italic> (<bold>C</bold>) showing the deletion of 45 bp in the 5â² end of exon 4 in the h<italic>FRMD7-S</italic>/m<italic>FRMD7-S</italic>. <bold>D</bold>: Agarose gel electrophoresis of the RTâPCR products to confirm their size and the identification of a single PCR product. E: Expression levels of h<italic>FRMD7-FL</italic> and h<italic>FRMD7-S</italic> transcripts in selected human fetal tissues. The primer sets used in <bold>D</bold> and <bold>E</bold>: p1f/p1r, p2f/p2r and p3f/p3r.</p>
          </caption>
          <graphic xlink:href="mv-v17-2986-f1"/>
        </fig>
      </sec>
      <sec>
        <title>Levels of both h<italic>FRMD7</italic> transcripts significantly increased in ATRA-induced differentiating NT2 cells</title>
        <p>As shown in <xref ref-type="fig" rid="f2">Figure 2A,B</xref>, the levels of h<italic>FRMD7-FL</italic> and h<italic>FRMD7-S</italic> mRNA expression in NT2 cells started to increase at 12 h after ATRA treatment and reached a maximal increase at 8 days (81 fold for h<italic>FRMD7-FL</italic> and 96 fold for h<italic>FRMD7-S</italic> relative to the 0 h time point; <xref ref-type="fig" rid="f2">Figure 2A,B</xref>). The control group did not exhibit any change relative to the 0 h time point. Compared to ATRA, BMP-2 had a repressive effect on h<italic>FRMD7-FL</italic> and h<italic>FRMD7-S</italic> expression. After 24 h of BMP-2 treatment, the levels of h<italic>FRMD7-FL</italic> and h<italic>FRMD7-S</italic> transcripts started to decline relative to the 0 h time point, and continued to decrease after 36 h; after 8 days, the expression levels of h<italic>FRMD7-FL</italic> and h<italic>FRMD7-S</italic> transcripts began to increase (<xref ref-type="fig" rid="f2">Figure 2C,D</xref>).</p>
        <fig id="f2" fig-type="figure" position="float">
          <label>Figure 2</label>
          <caption>
            <p>Effects of ATRA/BMP-2 induction on the expression of <italic>FRMD7</italic> splice variants in NT2 cells. <bold>A</bold> and <bold>B</bold>: NT2 cells were treated with ATRA (10 ÂµM) or vehicle (0.1% DMSO) for the indicated periods. <bold>C</bold> and <bold>D</bold>: NT2 cells were treated with BMP-2 (50 ng/ml) or vehicle (normal saline) for the indicated time periods. Expression levels of h<italic>FRMD7-FL</italic> and h<italic>FRMD7-S</italic> transcripts were determined by RT-qPCR. The vehicle-treated cells did not show any significant change (data not shown). The primer sets were used for RT-qPCR: p1f/p1r, p2f/p2r and p3f/p3r. Both the transcript levels are normalized to <italic>GAPDH</italic> mRNA levels. The data are presented as fold changes relative to 0 h. The experiments were done in triplicate, and the graphs represent the average of three independent experiments (Columns, mean; bars, S.E.M.; *p&lt;0.05, **p&lt;0.01 versus 0 h).</p>
          </caption>
          <graphic xlink:href="mv-v17-2986-f2"/>
        </fig>
      </sec>
      <sec>
        <title>hFRMD7-FL and hFRMD7-S co-localized with class III Î²-tubulin and exhibited differential effects on neurite development</title>
        <p>Stable NT2 cell lines overexpressing hFRMD7-FL-HA or hFRMD7-S-Myc were established for use in experiments to study their role during differentiation. We examined the co-localization of class III Î²-tubulin, which is not expressed at detectable levels in neural progenitor cells, with the two FRMD7 isoforms by indirect immunofluorescence. Both isoforms exhibited strong co-localization with neuronal class III Î²-tubulin in differentiating NT2 cells induced with ATRA for 5 days (<xref ref-type="fig" rid="f3">Figure 3A,B</xref>). Having established that the hFRMD7-FL or hFRMD7-S overexpressed cell lines, we next sought to find how this change would affect neurite development in differentiated NT2 cells. Notably, following ATRA treatment for 5 days, a significant increase in the length and number of neurites was observed in NT2 cells stably overexpressing hFRMD7-FL-HA NT2 (<xref ref-type="fig" rid="f3">Figure 3A,C</xref> and <xref ref-type="table" rid="t2">Table 2</xref>; p&lt;0.05). However, the degree of neurite branching did not differ between the control and hFRMD7-S overexpressing NT2 cells (<xref ref-type="fig" rid="f3">Figure 3B,C</xref> and <xref ref-type="table" rid="t2">Table 2</xref>; p&gt;0.05).</p>
        <fig id="f3" fig-type="figure" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Effects of h<italic>FRMD7-FL</italic> or h<italic>FRMD7-S</italic> overexpression on neurite outgrowth. NT2 cells stably transfected with hFRMD7-FL-HA (<bold>A</bold>), hFRMD7-S-Myc (<bold>B</bold>), or the empty pcDNA3.1(+) vector (<bold>C</bold>) were treated with ATRA for 5 days. The cells were fixed and immunostained with monoclonal anti-Myc or anti-HA antibodies and a DyLight-488 conjugated secondary antibody. Class III Î²-tubulin was immunostained using a monoclonal TuJ1 antibody and DyLight-594 secondary antibody. Magnification: 200Ã.</p>
          </caption>
          <graphic xlink:href="mv-v17-2986-f3"/>
        </fig>
        <table-wrap id="t2" position="float">
          <label>Table 2</label>
          <caption>
            <title>Neurite outgrowth of NT2 cells treated with 10 Î¼M retinoic acid.</title>
          </caption>
          <table frame="hsides" rules="groups">
            <col width="173" span="1"/>
            <col width="106" span="1"/>
            <col width="106" span="1"/>
            <col width="106" span="1"/>
            <thead>
              <tr>
                <th valign="top" align="left" scope="col" rowspan="1" colspan="1">
                  <bold>Norm</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>Control</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>hFRMD7-S</bold>
                </th>
                <th valign="top" align="center" scope="col" rowspan="1" colspan="1">
                  <bold>hFRMD7-FL</bold>
                </th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Percentage of cells with neurites*<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">46.2Â±2.1<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">47.5Â±1.3 (ns)<hr/></td>
                <td valign="top" align="center" rowspan="1" colspan="1">77.8Â±1.6<hr/></td>
              </tr>
              <tr>
                <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Average neurite length** (Î¼m)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">42.7Â±2.6</td>
                <td valign="top" align="center" rowspan="1" colspan="1">43.6Â±2.1 (ns)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">72.3Â±1.1</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>Cells were treated with 10 Î¼m retinoic acid, 10% FCS/DMEM-F12 for 5 days, and neurite parameters were quantified. Data are meanÂ±SEM of three independent experiments. At least 250 cells per transfection were counted. *Cells that possess at least one outgrowth of more than one-half the cell body diameter in length. **Neurite length from cell body to distal tip. (ns) stands for Not Significant.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>hFRMD7-FL co-localizes and interacts with hFRMD7-S in NT2 cells</title>
        <p>To investigate the subcellular co-localization of FRMD7 isoforms and to differentiate between the localization of endogenous FRMD7 and exogenously expressed FRMD7 proteins, we used expression vectors to express hFRMD7-FL or hFRMD7-S differentially tagged with green (EGFP) or red (DsRed) fluorescent protein, respectively. Following transient co-transfection with the fusion constructs encoding pEGFP-hFRMD7-FL and pDsRed-hFRMD7-S, untreated NT2 cells (without ATRA) and NT2 cells treated with ATRA for 7 days were subjected to fluorescence microscopy. In these experiments, EGFP-hFRMD7-FL and DsRed-hFRMD7-S exhibited a high degree of co-localization (<xref ref-type="fig" rid="f4">Figure 4</xref>); both isoforms were primarily localized in cytoplasm and perinuclear regions in undifferentiated NT2 cells (<xref ref-type="fig" rid="f4">Figure 4A</xref>). Similarly, in NT2 cells induced with ATRA for 7 days, EGFP-hFRMD7-FL and DsRed-hFRMD7-S co-localized extensively in the cytoplasm, perinuclear regions, and neurite processes. Notably, the distribution of EGFP-hFRMD7-FL was more abundant in the distal terminals of the neurites relative to that of DsRed-hFRMD7-S (<xref ref-type="fig" rid="f4">Figure 4B</xref>).</p>
        <fig id="f4" fig-type="figure" position="float">
          <label>Figure 4</label>
          <caption>
            <p>Sub-cellular co-localization and co-immunoprecipitation of hFRMD7-FL with hFRMD7-S. Co-transfection of pEGFP-hFRMD7-FL (green) and pDsRed-hFRMD7-S (red) into RA-untreated (<bold>A</bold>) or differentiating NT2 cells (<bold>B</bold>). After 48 h, the cells were fixed and DAPI was used as a nuclear counterstain (blue). Magnification 400Ã. <bold>C</bold> and <bold>D</bold>: Reciprocal co-immunoprecipitation experiments show that hFRMD7-FL-HA co-immunoprecipitates with hFRMD7-S-Myc, and vice versa, in NT2 cells. Cells transfected with only hFRMD7-S-Myc or hFRMD7-FL-HA served as the negative control.</p>
          </caption>
          <graphic xlink:href="mv-v17-2986-f4"/>
        </fig>
        <p>To test for proteinâprotein interactions, we performed co-IP experiments. We co-expressed HA and Myc NH<sub>2</sub>-terminally tagged versions of hFRMD7-FL (hFRMD7-FL-HA) and hFRMD7-S (hFRMD7-S-Myc), respectively, in NT2 cells. At 48 h post-transfection, total cell lysates were extracted, and hFRMD7-FL-HA was immunoprecipitated using anti-HA antibodies, followed by immunoblot analysis with anti-Myc antibodies. The results showed that hFRMD7-FL-HA co-immunoprecipitated with hFRMD7-S-Myc (<xref ref-type="fig" rid="f4">Figure 4C</xref>). This finding was confirmed by reciprocal immunoprecipitation experiments, which showed that hFRMD7-S-Myc co-immunoprecipitated with hFRMD7-FL-HA (<xref ref-type="fig" rid="f4">Figure 4D</xref>). The results of these experiments may suggest that hFRMD7-FL and hFRMD7-S either interact directly or are associated with the same protein complex in NT2 cells.</p>
      </sec>
      <sec>
        <title>hFRMD7-FL protein stimulates transcription of h<italic>FRMD7-S</italic></title>
        <p>Alternative splicing often impacts the transcription and subsequent translation of the major protein. Therefore, we performed experiments to determine whether overexpression of one <italic>FRMD7</italic> splice variant was associated with altered transcription of the other splice variant. Overexpression of h<italic>FRMD7-FL</italic> or h<italic>FRMD7-S</italic> was confirmed by RTâPCR and immunoblot analyses (data not shown). We found that the transcription levels of h<italic>FRMD7-S</italic> exhibited a time-dependent increase in cells overexpressing h<italic>FRMD7-FL</italic> relative to control cells, with an average of 4.8 fold higher h<italic>FRMD7-S</italic> expression levels at 72 h (<xref ref-type="fig" rid="f5">Figure 5A</xref>); in contrast, h<italic>FRMD7-FL</italic> transcription levels did not change significantly in NT2 cells overexpressing h<italic>FRMD7-S</italic> (<xref ref-type="fig" rid="f5">Figure 5B</xref>).</p>
        <fig id="f5" fig-type="figure" position="float">
          <label>Figure 5</label>
          <caption>
            <p>Overexpression of h<italic>FRMD7-FL</italic> stimulates h<italic>FRMD7-S</italic> transcription. Expression levels of h<italic>FRMD7-FL</italic> or h<italic>FRMD7-S</italic> transcripts were monitored by RT-qPCR in transfected NT2 cells at the indicated time points. Cells transfected with the empty vector served as the negative control (MOCK group). <bold>A</bold>: Expression levels of h<italic>FRMD7-S</italic> in NT2 cells overexpressing h<italic>FRMD7-FL</italic>. <bold>B</bold>: Expression levels of h<italic>FRMD7-FL</italic> in NT2 cells overexpressing h<italic>FRMD7-S</italic>. The primer sets were used for RT-qPCR: p1f/p1r, p2f/p2r and p3f/p3r. Both the transcript levels are normalized to <italic>GAPDH</italic> mRNA levels. The data are presented as the fold changes relative to MOCK group. All of the experiments were done in triplicate, and the graph represents the average (columns, mean; bars, S.E.M.; *p&lt;0.05, **p&lt;0.01 versus MOCK group).</p>
          </caption>
          <graphic xlink:href="mv-v17-2986-f5"/>
        </fig>
      </sec>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>The human <italic>FRMD7</italic> gene spans a region of 2,145 bp and comprises 12 exons. Until now, no <italic>FRMD7</italic> mRNA variants have been described. Herein, we report the discovery of a novel transcript, h<italic>FRMD7-S</italic>, from the human <italic>FRMD7</italic> gene generated by alternative splicing. An increased understanding of the h<italic>FRMD7-S</italic> variant relative to the original h<italic>FRMD7-FL</italic> transcript may help clarify the role of <italic>FRMD7</italic> splice variants in neuronal development and the pathogenesis of ICN.</p>
      <p>We found that the h<italic>FRMD7-FL</italic> and h<italic>FRMD7-S</italic> transcripts exhibit a similar tissue distribution, with highest levels in the cerebellum; neither h<italic>FRMD7-FL</italic> nor h<italic>FRMD7-S</italic> were expressed in the medulla oblongata or pons. These results corroborate previous studies in mouse models [<xref ref-type="bibr" rid="r15">15</xref>]. Further, our previous studies demonstrated that h<italic>FRMD7-FL</italic> expression is ubiquitous during fetal brain development, but is restricted to regions of eye movement in adults [<xref ref-type="bibr" rid="r25">25</xref>]. We may suppose that the <italic>FRMD7</italic> transcripts may carry out cerebellum-associated functions (e.g., vestibulo-cerebellar system regulation of normal eye movement). Nevertheless, in the previous work, using immunohistochemistry testing, <italic>FRMD7-FL</italic> was observed to be highly expressed in the pons and medulla oblongata. Since the size differences in the corresponding mRNAs and protein isoforms are very small (i.e., 2,145 bp for h<italic>FRMD7-FL</italic> versus 2,100 bp for h<italic>FRMD7-S</italic>), neither northern blot nor immunoblot analyses were performed to determine endogenous hFRMD7-FL and hFRMD7-S protein expression. The reason for the differences of expression distribution between RNA level and protein level of FRMD7-FL are worth exploring in future studies.</p>
      <p>Recent studies suggest that ATRA-induced differentiation is followed by the upregulation of h<italic>FRMD7-FL</italic> mRNA and protein expression levels in NEURO2A cells [<xref ref-type="bibr" rid="r14">14</xref>]. In the current study, we found that ATRA-induced neuronal differentiation of NT2 cells resulted in elevated expression of both h<italic>FRMD7-FL</italic> and h<italic>FRMD7-S</italic> transcripts, whereas BMP-2 treatment of NT2 cells had a repressive effect on h<italic>FRMD7-FL</italic> and h<italic>FRMD7-S</italic> expression. Further, a recent study demonstrated that downregulation of h<italic>FRMD7-FL</italic> in NEURO2A cells resulted in altered neurite development [<xref ref-type="bibr" rid="r14">14</xref>]. In the current study, we found that h<italic>FRMD7-FL</italic> overexpression leads to a significant increase in neurite length in differentiating NT2 cells; however, h<italic>FRMD7-S</italic> overexpression had no effect on this process.</p>
      <p>NT2 cells undergo programmed terminal differentiation along a neuronal pathway, resulting in the accumulation of neuronal cells with neurite outgrowths and extended processes within a period of 8 days. Thus, we speculate that both h<italic>FRMD7-FL</italic> and h<italic>FRMD7-S</italic> are involved in the process of neurite outgrowth extension. Since h<italic>FRMD7-FL</italic> and h<italic>FRMD7-S</italic> share highly similar sequences, their different effect on ATRA-induced NT2 differentiation is of particular interest. Although it is unclear what underlies these differences, our findings suggest that the <italic>FRMD7</italic> isoforms are involved in the formation and growth of neurites during neuronal differentiation, and also provide evidence that the h<italic>FRMD7-S</italic> isoform may play a minor role during this process.</p>
      <p>A previous study showed that <italic>FARP1</italic> and <italic>FARP2</italic>, which share homology with <italic>FRMD7</italic>, are involved in signal transduction between the plasma membrane and cytoskeleton, and that the hFRMD7-FL protein co-localizes with actin in NEURO2A cells [<xref ref-type="bibr" rid="r12">12</xref>-<xref ref-type="bibr" rid="r14">14</xref>,<xref ref-type="bibr" rid="r26">26</xref>,<xref ref-type="bibr" rid="r27">27</xref>]. In the current study, we found that hFRMD7-FL and hFRMD7-S splice variants also exhibit strong co-localization with class III Î²-tubulin, which is considered to be one of the earliest neuron-associated cytoskeletal marker proteins during mammalian development [<xref ref-type="bibr" rid="r28">28</xref>,<xref ref-type="bibr" rid="r29">29</xref>]. These results give evidence that the FRMD7 isoforms carry out functions associated with microtubules and cytoskeleton-associated proteins or at least play a role in a related molecular pathway.</p>
      <p>We found that the hFRMD7-FL isoform co-localized to a high extent with the hFRMD7-S isoform in undifferentiated and differentiating NT2 cells, although the hFRMD7-FL isoform exhibited a more abundant distribution in the distal terminals of axon branches relative to the hFRMD7-S isoform. These differences may be due to different levels of protein translation efficiency. Further, the results of our reciprocal co-IP experiments also suggest that hFRMD7-FL and hFRMD7-S interact in NT2 cells. Taken together, these results uncovered a putative protein complex formed by the two FRMD7 isoforms; however, further studies will be required to confirm this finding.</p>
      <p>Notably, we also found that h<italic>FRMD7-FL</italic> overexpression led to the stimulation of h<italic>FRMD7-S</italic> gene expression in NT2 cells, whereas overexpression of h<italic>FRMD7-S</italic> showed no significant effect on h<italic>FRMD7-FL</italic> expression. These results indicate that h<italic>FRMD7-FL</italic> might be involved in h<italic>FRMD7-S</italic> regulation. Considering their different effects on ATRA-induced NT2 differentiation, we speculate that h<italic>FRMD7-S</italic> plays a less important role of biologic functions. Although the mechanism(s) by which <italic>FRMD7-FL</italic> regulates h<italic>FRMD7-S</italic> expression remains elusive, we speculate that the altered FERM domain in hFRMD7-S may explain its inability to regulate h<italic>FRMD7-FL</italic> expression.</p>
      <p>In conclusion, we identified a novel <italic>FRMD7</italic> variant generated by alternative mRNA splicing that results in the deletion of 45 base pairs in exon 4. This is the first splice variant of <italic>FRMD7</italic> to be reported. The two isoforms share a similar tissue distribution, and they co-localize and interact with each other in NT2 cells. However, the hFRMD7-S isoform showed a slightly limited tissue distribution and a limited function in altering the length and number of neurites in differentiating NT2 cells relative to the hFRMD7-FL isoform. Taken together, although the significance of the 45 bp deletion remains unknown, our observations suggest that the FRMD7 isoforms may play a significant role during neuronal differentiation and development. Therefore, although additional studies will be required to further confirm the association between the two transcripts, the current findings may enhance our understanding of their precise functional roles in the pathogenesis of ICN.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p>This work was supported by grants from the National Natural Science Foundation of China [81070903 to B.Z.]. We thank the parents who donated the abortions. We also thank all medical staff at the Women's Hospital School Of Medicine Zhejiang University for their dedication in this study.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Thomas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Proudlock</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Sarvananthan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>EO</given-names>
            </name>
            <name>
              <surname>Awan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>McLean</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Surendran</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kumar</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Farooq</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Degg</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Gale</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Reinecke</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Woodruff</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Langmann</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lindner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jain</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Tarpey</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Raymond</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Gottlob</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Phenotypical characteristics of idiopathic infantile nystagmus with and without mutations in FRMD7.</article-title>
          <source>Brain</source>
          <year>2008</year>
          <volume>131</volume>
          <fpage>1259</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="pmid">18372314</pub-id>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sarvananthan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Surendran</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Jain</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Proudlock</surname>
              <given-names>FA</given-names>
            </name>
            <name>
              <surname>Thompson</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>McLean</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Degg</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Woodruff</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gottlob</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>The prevalence of nystagmus: the Leicestershire nystagmus survey.</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2009</year>
          <volume>50</volume>
          <fpage>5201</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">19458336</pub-id>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Surgical management of nystagmus.</article-title>
          <source>J R Soc Med</source>
          <year>2002</year>
          <volume>95</volume>
          <fpage>238</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">11983764</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jacobs</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>DellâOsso</surname>
              <given-names>LF</given-names>
            </name>
          </person-group>
          <article-title>Congenital nystagmus, hypotheses for its genesis and complex waveforms within a behavioral ocular motor system model.</article-title>
          <source>J Vis</source>
          <year>2004</year>
          <volume>4</volume>
          <fpage>604</fpage>
          <lpage>25</lpage>
          <pub-id pub-id-type="pmid">15330705</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tarpey</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sarvananthan</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Mallya</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Lisgo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Talbot</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>EO</given-names>
            </name>
            <name>
              <surname>Awan</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Surendran</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>McLean</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Reinecke</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Langmann</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lindner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Koch</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jain</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Woodruff</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gale</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Degg</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Droutsas</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Asproudis</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Zubcov</surname>
              <given-names>AA</given-names>
            </name>
            <name>
              <surname>Pieh</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Veal</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Machado</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Backhouse</surname>
              <given-names>OC</given-names>
            </name>
            <name>
              <surname>Baumber</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Constantinescu</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Brodsky</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Hunter</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Hertle</surname>
              <given-names>RW</given-names>
            </name>
            <name>
              <surname>Read</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>Edkins</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>O'Meara</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Teague</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wooster</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Futreal</surname>
              <given-names>PA</given-names>
            </name>
            <name>
              <surname>Trembath</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Stratton</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Raymond</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Gottlob</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus.</article-title>
          <source>Nat Genet</source>
          <year>2006</year>
          <volume>38</volume>
          <fpage>1242</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">17013395</pub-id>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Self</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lotery</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>A review of the molecular genetics of congenital idiopathic nystagmus (CIN).</article-title>
          <source>Ophthalmic Genet</source>
          <year>2007</year>
          <volume>28</volume>
          <fpage>187</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">18161616</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Xie</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Hu</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Song</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Ding</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Xia</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Novel mutations of the FRMD7 gene in X-linked congenital motor nystagmus.</article-title>
          <source>Mol Vis</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>1674</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">17893669</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leto</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Marchesi</surname>
              <given-names>VT</given-names>
            </name>
          </person-group>
          <article-title>A structural model of human erythrocyte protein 4.1.</article-title>
          <source>J Biol Chem</source>
          <year>1984</year>
          <volume>259</volume>
          <fpage>4603</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">6707022</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bretscher</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Reczek</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Berryman</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures.</article-title>
          <source>J Cell Sci</source>
          <year>1997</year>
          <volume>110</volume>
          <fpage>3011</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">9365271</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tepass</surname>
              <given-names>U</given-names>
            </name>
          </person-group>
          <article-title>FERM proteins in animal morphogenesis.</article-title>
          <source>Curr Opin genet Dev</source>
          <year>2009</year>
          <volume>19</volume>
          <fpage>357</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="pmid">19596566</pub-id>
        </element-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kubo</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamashita</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yamaguchi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sumimoto</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Hosokawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tohyama</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>A novel FERM domain including guanine nucleotide exchange factor is involved in Rac signaling and regulates neurite remodeling.</article-title>
          <source>J Neurosci</source>
          <year>2002</year>
          <volume>22</volume>
          <fpage>8504</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">12351724</pub-id>
        </element-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhuang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Sockanathan</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>FARP1 promotes the dendritic growth of spinal motor neuron subtypes through transmembrane Semaphorin6A and PlexinA4 signaling.</article-title>
          <source>Neuron</source>
          <year>2009</year>
          <volume>61</volume>
          <fpage>359</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="pmid">19217374</pub-id>
        </element-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toyofuku</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yoshida</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sugimoto</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Kumanogoh</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hori</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kikutani</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>FARP2 triggers signals for Sema3A-mediated axonal repulsion.</article-title>
          <source>Nat Neurosci</source>
          <year>2005</year>
          <volume>8</volume>
          <fpage>1712</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">16286926</pub-id>
        </element-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Betts-Henderson</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bartesaghi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Crosier</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lindsay</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Salomoni</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gottlob</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Nicotera</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>The nystagmus-associated FRMD7 gene regulates neuronal outgrowth and development.</article-title>
          <source>Hum Mol Genet</source>
          <year>2010</year>
          <volume>19</volume>
          <fpage>342</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="pmid">19892780</pub-id>
        </element-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Self</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Haitchi</surname>
              <given-names>HM</given-names>
            </name>
            <name>
              <surname>Griffiths</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Holgate</surname>
              <given-names>ST</given-names>
            </name>
            <name>
              <surname>Davies</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Lotery</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Frmd7 expression in developing mouse brain.</article-title>
          <source>Eye (Lond)</source>
          <year>2010</year>
          <volume>24</volume>
          <fpage>165</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">19265863</pub-id>
        </element-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andrews</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
          <article-title>Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro.</article-title>
          <source>Dev Biol</source>
          <year>1984</year>
          <volume>103</volume>
          <fpage>285</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">6144603</pub-id>
        </element-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pleasure</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Page</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>VM-Y</given-names>
            </name>
          </person-group>
          <article-title>Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons.</article-title>
          <source>J Neurosci</source>
          <year>1992</year>
          <volume>12</volume>
          <fpage>1802</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">1578271</pub-id>
        </element-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chadalavada</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Houldsworth</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Olshen</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Bosl</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Studer</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Chaganti</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Transcriptional program of bone morphogenetic protein-2-induced epithelial and smooth muscle differentiation of pluripotent human embryonal carcinoma cells.</article-title>
          <source>Funct Integr Genomics</source>
          <year>2005</year>
          <volume>5</volume>
          <fpage>59</fpage>
          <lpage>69</lpage>
          <pub-id pub-id-type="pmid">15690164</pub-id>
        </element-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Caricasole</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Ward-van, Oostwaard, D., Zeinstra, L., van, den, Eijnden-van, Raaij, A., Mummery, C. Bone morphogenetic proteins (BMPs) induce epithelial differentiation of NT2D1 human embryonal carcinoma cells.</article-title>
          <source>Int J Dev Biol</source>
          <year>2000</year>
          <volume>44</volume>
          <fpage>443</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">11032177</pub-id>
        </element-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lopez</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation.</article-title>
          <source>Annu Rev Genet</source>
          <year>1998</year>
          <volume>32</volume>
          <fpage>279</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="pmid">9928482</pub-id>
        </element-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Blencowe</surname>
              <given-names>BJ</given-names>
            </name>
          </person-group>
          <article-title>Alternative splicing: new insights from global analyses.</article-title>
          <source>Cell</source>
          <year>2006</year>
          <volume>126</volume>
          <fpage>37</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="pmid">16839875</pub-id>
        </element-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dredge</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Polydorides</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Darnell</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <article-title>The splice of life: alternative splicing and neurological disease.</article-title>
          <source>Nat Rev Neurosci</source>
          <year>2001</year>
          <volume>2</volume>
          <fpage>43</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">11253358</pub-id>
        </element-citation>
      </ref>
      <ref id="r23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Licatalosi</surname>
              <given-names>DD</given-names>
            </name>
            <name>
              <surname>Darnell</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <article-title>Splicing regulation in neurologic disease.</article-title>
          <source>Neuron</source>
          <year>2006</year>
          <volume>52</volume>
          <fpage>93</fpage>
          <lpage>101</lpage>
          <pub-id pub-id-type="pmid">17015229</pub-id>
        </element-citation>
      </ref>
      <ref id="r24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Livak</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Schmittgen</surname>
              <given-names>TD</given-names>
            </name>
          </person-group>
          <article-title>Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2-â³â³CT Method.</article-title>
          <source>Methods</source>
          <year>2001</year>
          <volume>25</volume>
          <fpage>402</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">11846609</pub-id>
        </element-citation>
      </ref>
      <ref id="r25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>YZ</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>ZR</given-names>
            </name>
            <name>
              <surname>Yan</surname>
              <given-names>YP</given-names>
            </name>
            <name>
              <surname>Tian</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>BR</given-names>
            </name>
          </person-group>
          <article-title>Expression and localization of FRMD7 in human fetal brain, and a role for F-actin.</article-title>
          <source>Mol Vis</source>
          <year>2011</year>
          <volume>17</volume>
          <fpage>591</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">21386928</pub-id>
        </element-citation>
      </ref>
      <ref id="r26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhuang</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Su</surname>
              <given-names>YS</given-names>
            </name>
            <name>
              <surname>Sockanathan</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>FARP1 promotes the dendritic growth of spinal motor neuron subtypes through transmembrane Semaphorin6A and PlexinA4 signaling.</article-title>
          <source>Neuron</source>
          <year>2009</year>
          <volume>61</volume>
          <fpage>359</fpage>
          <lpage>72</lpage>
          <pub-id pub-id-type="pmid">19217374</pub-id>
        </element-citation>
      </ref>
      <ref id="r27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nikolic</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>The role of Rho GTPases and associated kinases in regulating neurite outgrowth.</article-title>
          <source>Int J Biochem Cell Biol</source>
          <year>2002</year>
          <volume>34</volume>
          <fpage>731</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">11950591</pub-id>
        </element-citation>
      </ref>
      <ref id="r28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katsetos</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Herman</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>MÃ¶rk</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Class III beta-tubulin in human development and cancer.</article-title>
          <source>Cell Motil Cytoskeleton</source>
          <year>2003</year>
          <volume>55</volume>
          <fpage>77</fpage>
          <lpage>96</lpage>
          <pub-id pub-id-type="pmid">12740870</pub-id>
        </element-citation>
      </ref>
      <ref id="r29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katsetos</surname>
              <given-names>CD</given-names>
            </name>
            <name>
              <surname>Frankfurter</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Christakos</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mancall</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Vlachos</surname>
              <given-names>IN</given-names>
            </name>
            <name>
              <surname>Urich</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Differential localization of class III, beta-tubulin isotype and calbindin-D28k defines distinct neuronal types in the developing human cerebellar cortex.</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>1993</year>
          <volume>52</volume>
          <fpage>655</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">8229085</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>